
Corcept’s ovarian cancer drug meets main goal in late-stage study, shares jump
Audio By Carbonatix (Reuters) -Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a type of ovarian cancer without the disease getting worse in a late-stage trial, sending the company’s …